CLXT
Calyxt, Inc. [CLXT] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CLXT Stock Summary
In the News
CLXT Financial details
Company Rating
-
Market Cap
31.33M
Income
-53.43M
Revenue
756K
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
48
Optionable
No
Shortable
Yes
Earnings
02 Aug 2023
P/E
-2.55
Forward P/E
-
PEG
0.28
P/S
187.63
P/B
11.67
P/C
-
P/FCF
-1.92
Quick Ratio
0.49
Current Ratio
0.61
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-3.33
EPS next Y
-
EPS next Q
-
EPS this Y
-72.53%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
63.58%
Revenue last 5Y
-7.83%
Revenue Q/Q
141.12%
EPS Q/Q
-46.67%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-60%
ROE
-150%
ROC
-1.29%
Gross Margin
100%
Oper. Margin
-12422%
Profit Margin
-7311%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
6.01-38.85
52W High
-
52W Low
-
RSI
50
Rel Volume
11.28
Avg Volume
22.52K
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
2.04328
-
-
Volatility
6.23%, 6.23%
Prev Close
-
Price
-
Change
-
Company Profile
- Volume Average 22.52K
- Market Capitalization 31.33M
- Employee 48
- CEO Mr. Michael Allen Carr
- Headquarters Roseville,MN,US
- IPO Date 2017-07-20
-
Website
https://calyxt.com 
Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company for the exclusive license of an improved quality alfalfa seed in the United States and internationally. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was incorporated in 2010 and is headquartered in Roseville, Minnesota. Calyxt, Inc. is a subsidiary of Cellectis S.A.
